Effectiveness of an implementation strategy of Clinical Practice Guideline for patients with anxiety disorders in Primary Care

ISRCTN ISRCTN83365316
DOI https://doi.org/10.1186/ISRCTN83365316
Secondary identifying numbers PI09/90304
Submission date
18/06/2010
Registration date
04/08/2010
Last edited
29/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs M Eugenia Tello
Scientific

Avda. de los Pinos, 30.
Leganés
28914
Spain

Study information

Study designMulticentre cluster randomised 2 arm open label controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a patient information sheet
Scientific titleCluster randomized trial for evaluate the effectiveness of an implementation strategy of a clinical practice guideline for patients with anxiety disorders
Study acronymGRITA
Study objectivesThe percentage of patients with a decrease of 2 or more points in the Goldberg Anxiety Scale after 6 months, will be 20% higher in those that were involved in the focused organisational strategy over those that weren’t involved in it.
Ethics approval(s)The Committee of Ethical Investigation of the 9th Madrid Health Area approved on the 29th of April 2010
Health condition(s) or problem(s) studiedGeneralised anxiety disorder, panic disorder and panic attacks
Intervention1. Control group:
1.1. The Clinical Practice Guideline (CPG) will be included on the official working place website
1.2. The CPG will be presented in a formative session of 2 hours of length to which will be invited to assist 1 or 2 members of each one of the 22 Health Centres involved in the study

2. Intervention group:
2.1. They will also receive an special formative session of 2 hours of length focused on the professionals with the protocol of intervention
2.2. They will receive special educational material as information sheets for patients, quick guides, etc.
2.3. A local opinion leader will be chosen on each team as the responsible person for the CPG
2.4. A defined system for reminding, audit and feedback will be developed to give back information about the intermediate results of the study at 3 and 6 months of the beginning.
Intervention typeOther
Primary outcome measure1. Variation of 2 or more points in the Goldberg Anxiety Scale
2. Evaluative criteria
2.1. 4 or more affirmative responses in the Anxiety subscale
2.2. 2 or more affirmative responses in the Depression subscale
Outcomes will be measured at baseline, 6 and 12 months.
Secondary outcome measures1. Compliance with the Guideline recommendations on treatment
2. Information and referrals to Mental Health Services
Outcomes will be measured at baseline, 6 and 12 months in data collecting notebooks
Overall study start date15/09/2010
Completion date15/09/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsSample size adjusted for design effect = 296 (148 in each arm)
Key inclusion criteria1. Patients older than 18
2. Diagnosed as generalised anxiety disorder, panic disorder and panic attacks by Diagnostic and Statistical Manual of Mental Disorders 4th edition (text revision) (DSM-IV-TR)
3. Signed informed consent
Key exclusion criteria1. Subjects that have been diagnosed of one of the following types of anxiety:
1.1. Post-traumatic stress disorders
1.2. Acute stress disorders
1.3. drug-related anxiety disorders
1.4. Anxiety disorders due to a medical or a mental illness
2. Subjects not able to read or understand Spanish language
3. Subjects that will not stay living on the Health Area in the next year after their inclusion on the study
4. Institutionalised or immobilised patients
Date of first enrolment15/09/2010
Date of final enrolment15/09/2012

Locations

Countries of recruitment

  • Spain

Study participating centre

Avda. de los Pinos, 30.
Leganés
28914
Spain

Sponsor information

Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)
Hospital/treatment centre

General Sub-Department for the Evaluation and Promotion of Research
(Subdirección General Evaluación y Fomento de la Investigación)
Monforte de Lemos, 5
Madrid
28029
Spain

ROR logo "ROR" https://ror.org/00ca2c886

Funders

Funder type

Hospital/treatment centre

Carlos III Health Institute (Instituto de Salud Carlos III) (Spain) - Spanish Ministry of Health Supporting Investigation Department (ref: PI09/90304)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/12/2011 29/12/2020 Yes No

Editorial Notes

29/12/2020: Publication reference added.